You can use your existing Medical Independent, MediLearning or PharmacistCPD account to log in.


Medicalindependent.ie is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.


The benefits of registering: only registered users:
  • receive the ecCopy two days prior to the printed edition.
  • have automatic access to our free CPD sites.
  • can partake in our online MCQs.
  • can enter our online sports quiz.

Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

Download the new Mindo app for both IOS & Android.

  • Get notified when a story goes live
  • Access Premium Content
  • Read Offline
 
[the_ad_placement id="main-ldb-public"]
[the_ad_placement id="main-ldb-mobile-public"]

You are reading 1 of 2 free-access articles allowed for 30 days

CJD protocols consultation process underway

By Dermot - 12th Jan 2017 | 3 views

This protocol guides on the follow-up required following a report of a newly diagnosed or suspected case of CJD/vCJD; a person at increased risk of CJD/vCJD; and an invasive procedure carried out on a patient with CJD/vCJD or at increased risk of CJD/vCJD, where TSE infection control guidelines were not followed. The document is based on current UK guidance.

According to the HPSC, universal assessment of CJD/vCJD risk for all patients about to undergo an invasive procedure is not recommended due to the lower population risk of vCJD in Ireland compared to the UK.

However, all patients about to undergo a neurosurgical procedure (including spinal and neuro-endoscopy procedures) or an ophthalmological procedure likely to involve contact with tissues of potentially high levels of TSE infectivity should have their CJD/vCJD risk assessed and documented as part of the routine pre-operative assessment process.

The HPSC is inviting comments and suggestions on any aspect of its document including content and layout, etc. The consultation proforma is available on the HPSC website. The final date for submission of comments is 3 February.

Leave a Reply

[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]
Latest Issue
The Medical Independent – 24 June 2021

You need to be logged in to access this content. Please login or sign up using the links below.

[the_ad_placement id="main-mpu-public"]
Most Read
[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]